Bolt Biotherapeutics
About:
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
Website: http://boltbio.com/
Top Investors: Novo Holdings, RA Capital Management, Samsara BioCapital, Sofinnova Investments, Surveyor Capital
Description:
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. Its platform, Boltbody, is a cancer immunotherapy that consists of immune-stimulating antibody conjugates.
Total Funding Amount:
$199M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Redwood City, California, United States
Founded Date:
2015-01-01
Contact Email:
info(AT)bOLTBIO.com
Founders:
Chih-Ping Liu, Edgar Engleman
Number of Employees:
51-100
Last Funding Date:
2021-06-07
IPO Status:
Public
Industries:
© 2025 bioDAO.ai